Fabio Cataldi's most recent trade in Landos Biopharma Inc was a trade of 21,138 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 29, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Landos Biopharma Inc | Fabio Cataldi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 21,138 | 21,138 | - | - | Restricted Stock Unit | |
| Landos Biopharma Inc | Fabio Cataldi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 276,750 | 276,750 | - | - | Restricted Stock Unit | |
| Landos Biopharma Inc | Fabio Cataldi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 184,500 | 184,500 | - | - | Employee Stock Option (right to buy) | |
| Landos Biopharma Inc | Fabio Cataldi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2022 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) |